• QNZ (EVP4593): Reliable NF-κB Assays

  2026-08-17

  This scenario-based guide shows how QNZ (EVP4593), SKU A4217, can be integrated into NF-κB, viability, proliferation, and cytotoxicity workflows without confusing pathway inhibition with nonspecific cell injury. It covers assay design, solvent control, stock preparation, data interpretation, and practical vendor selection.

• Necrostatin-1: RIP1 Kinase Inhibitor Guide

  2026-08-17

  Necrostatin-1 is a selective RIP1 kinase inhibitor used to interrogate necroptosis, inflammation, and tissue injury. Product data report blockade of TNF-α-induced necroptosis, while peer-reviewed work connects RIP1–RIP3 signaling with inflammatory pulmonary dysfunction.

• Rocket-Like Nanomedicine Restores PDAC Stroma

  2026-08-16

  Fu and colleagues developed an acid-responsive, sequential-release nanomedicine that combines stromal remodeling with gemcitabine delivery in pancreatic ductal adenocarcinoma. By releasing halofuginone and IPR-803 before gemcitabine-loaded mesoporous silica nanoparticles, the platform restored aspects of stromal homeostasis and produced marked tumor regression in a PDAC mouse model.

• Maraviroc: CCR5 Biology from HIV to Stroke

  2026-08-15

  Maraviroc (UK-427857) is a selective CCR5 antagonist for dissecting HIV-1 entry inhibition and chemokine signaling. This article presents a compartment- and time-aware framework for connecting HIV tropism studies with emerging neuroinflammation modulation research without overstating translational evidence.

• Ibrutinib and the Next Era of BTK Translation

  2026-08-14

  Ibrutinib and PCI-32765 offer a powerful framework for interrogating BTK-dependent biology, from B-cell receptor signaling inhibition and chronic lymphocytic leukemia research to autoimmune disease models. This thought-leadership article connects covalent target engagement with experimental design, translational stratification, and the responsible interpretation of cross-domain evidence.

• One-step TUNEL FITC Apoptosis Detection Kit Workflow

  2026-08-14

  Build a reproducible DNA fragmentation assay for tissue sections, adherent cells, suspension cells, and flow cytometry. This workflow connects TUNEL-positive cell mapping with the omics-anchored reproductive toxicity findings reported for gestational polystyrene nano-plastics exposure.

• Trelagliptin succinate in Bone and Diabetes Research

  2026-08-13

  Trelagliptin succinate, also known as SYR-472 succinate, supports integrated studies of DPP-4 biology, glucose regulation, and osteoblast differentiation. This practical guide connects assay setup, AMPK–RUNX2 validation, metabolic models, and troubleshooting for more reproducible diabetes mellitus research.

• 3X (DYKDDDDK) Peptide: Uses & Workflow

  2026-08-13

  The 3X (DYKDDDDK) Peptide is a compact, hydrophilic FLAG epitope reagent for antibody-based detection and affinity workflows. Its reported solubility and storage conditions support routine handling, while metal sensitivity and sequence verification remain important controls.

• Methyl-β-cyclodextrin: Membrane Workflow Guide

  2026-08-12

  Methyl-β-cyclodextrin is a research reagent for controlled membrane cholesterol extraction and related studies of lipid organization, membrane fluidity, and cholesterol-dependent signaling. It should be optimized for each cell and assay system, used promptly after solution preparation, and not used for diagnostic, therapeutic, or medical applications.

• Fenipentol: From Choleresis to Translational Biology

  2026-08-12

  Fenipentol, also known as 1-Phenyl-1-pentanol, offers a distinctive bridge between historical secretion physiology, ESR1-linked molecular hypotheses, and modern translational study design. This thought-leadership article explains how to validate its biology without conflating it with the related but chemically distinct 1-Phenyl-2-Pentanol, identified in recent hepatic stellate cell research.

• PPT: An ERα Perturbation Framework for LUAD

  2026-08-11

  PPT (Propyl Pyrazole Triol) is more than a selective ERα agonist: it can serve as a causal perturbation tool for separating receptor biology from biomarker correlation. This guide connects PPT assay design with FOXM1–ERα findings in female lung adenocarcinoma while defining practical controls, limits, and translational opportunities.

• TBST for Cleaner Immunoassay Signal

  2026-08-11

  TBST combines isotonic buffering with mild non-ionic detergent action to reduce nonspecific binding in Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. Its greatest practical value is workflow consistency: one defined buffer can support blocking, antibody dilution, and post-incubation washing while preserving interpretable target-specific signal.

• Annexin V-FITC/PI Apoptosis Assay Kit Workflow

  2026-08-10

  Use Annexin V-FITC and PI staining to separate viable, early apoptotic, and membrane-compromised cells in a rapid, two-parameter workflow. This guide translates findings from a conjugated linoleic acid study into practical assay design, gating, optimization, and troubleshooting for intestinal epithelial injury models.

• CHIR 99021 Trihydrochloride for Organoid Assays

  2026-08-09

  CHIR 99021 trihydrochloride is a selective GSK-3 inhibitor for studying stem-cell state, intestinal organoid composition, insulin signaling, and glucose metabolism. This article presents an assay-design framework that separates pathway engagement from proliferation and differentiation outcomes.

• LY364947: TGF-β Type I Receptor Kinase Inhibitor

  2026-08-08

  LY364947 gives researchers a reversible way to interrogate TGF-β-driven Smad2 signaling, EMT, fibrosis, and retinal injury responses. This practical guide covers solvent handling, pathway-resolved assay design, combination studies inspired by pancreatic cancer research, and troubleshooting strategies.

7700 records 8/514 page Previous Next First page 上5页 678910 下5页 Last page